SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-035812
Filing Date
2023-11-01
Accepted
2023-11-01 09:14:09
Documents
12
Period of Report
2023-11-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K ryzb-20231101.htm   iXBRL 8-K 27935
  Complete submission text file 0001628280-23-035812.txt   162051

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ryzb-20231101.xsd EX-101.SCH 1892
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ryzb-20231101_lab.xml EX-101.LAB 26155
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ryzb-20231101_pre.xml EX-101.PRE 13575
6 EXTRACTED XBRL INSTANCE DOCUMENT ryzb-20231101_htm.xml XML 2911
Mailing Address 5505 MOREHOUSE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE, SUITE 300 SAN DIEGO CA 92121 (619) 937-2754
RayzeBio, Inc. (Filer) CIK: 0001825367 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41799 | Film No.: 231366776
SIC: 2834 Pharmaceutical Preparations